.png)
SummaryGermany has no single drug database that covers everything. The landscape splits into official registers, professional reference works, article-master and pricing systems built on ABDATA and IFA data, and integrated platforms that consolidate many sources into one search. For healthcare professionals the practical question is not which database is best in the abstract, but which combination fits their role, and whether one consolidated search can replace licensing several silos. This guide compares the categories by the criteria that matter to pharmaceutical trade, hospital pharmacy, payers, industry and international market-access teams. It is written for professionals, not patients.
A German drug database is a structured collection of medicinal-product data for the German market: identifiers such as the PZN (Pharmazentralnummer), prescription and distribution status, prices, package information, active ingredients, interactions and regulatory status. No single source holds all of this at the same depth. Official registers focus on approval data, professional reference works on clinical short texts, article-master systems on logistics and prices.
Professionals therefore either combine several databases or use a platform that queries them together. The cost of the first approach is not only the licence fees but the manual work of reconciling identifiers and update cycles across sources. That is the problem the comparison below is meant to make concrete.
The German landscape falls into five system classes:
The table compares the classes on the criteria that decide day-to-day usefulness for professionals, rather than a feature-by-feature vendor list.
| System class | Data breadth | Currency | International | API / raw data | Best-fit role |
|---|---|---|---|---|---|
| Official register (BfArM / AMIce) | approval and product data | on regulatory change | DE focus | limited, partly open | regulatory affairs |
| Professional reference work | clinical short texts, indications | periodic | DE focus | limited | clinical look-up |
| Article-master and pricing system | identifiers, prices, status | frequent | DE focus | via data licence | trade, logistics |
| Classic pharmacy-tax system | prices, ordering | frequent | DE only | limited | community pharmacy |
| Integrated platform (pharmazie.com) | 25+ databases in one search | daily; prices bi-weekly | 50+ countries | REST API, data licensing | trade, hospital, payer, industry, international |
Two names dominate German article-master data, and they do different jobs. IFA GmbH (Informationsstelle für Arzneispezialitäten) assigns the PZN and runs the reporting process through which manufacturers submit their products. The IFA Article Master is the official, authoritative data basis for medicinal products approved in Germany.
ABDATA Pharma-Daten-Service, operated by Avoxa and formerly ABDA-branded, is the data originator of the ABDA database. It enriches the basis with pharmacological and clinical data, interactions and patient-individual risk checks. In short: IFA identifies and lists, ABDATA enriches. An integrated platform such as pharmazie.com includes the ABDA article master alongside further sources, so professionals see identification, clinical and price data in one result.
The ABDA database is the enriched data collection behind many professional systems, strong on interactions and medication safety. The Rote Liste is a curated directory of marketed medicinal products with short texts derived from product information, not the full SmPCs. The Gelbe Liste Pharmindex, from Vidal MMI, is a reference directory widely used in the hospital segment. They overlap in purpose but differ in depth, editorial focus and licensing, which is why many organisations end up subscribing to more than one. A consolidated search removes that redundancy by querying the sources together, as explained in our drug data API guide.
The right choice follows the job to be done:
For system integrators, software vendors and cross-border buyers, the question is often less about the interface and more about the data feed. Raw data access to article-master and pricing data may require a data licence from the data provider, and the allowed caching duration is tied to the update cadence. An integrated platform can deliver the same consolidated data through a REST API and data licensing in customer-specific formats, which is covered in our guide to the ABDA database.
The recurring theme across all five system classes is fragmentation: identifiers in one source, clinical data in another, prices in a third, international equivalents nowhere at all. pharmazie.com is the consolidated pharmaceutical data platform by DACON Datenbank Consulting GmbH that bundles 25+ specialist databases into a single search, exclusively for healthcare professionals. The Eisbergsuche® reaches a research result in 2 to 5 clicks that would otherwise require 3 to 4 separate systems, across 50,000+ German preparations, 120,000+ international trade products and product data from 50+ countries, updated daily. The clearest way to judge the fit for your role is a short demo.
Further reading: The ABDA database · Drug data API
